LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery.

    Choudhury, Ashok / Reddy, Golamari Srinivasa / Venishetty, Shantan / Pamecha, Viniyendra / Shasthry, Saggere Muralikrishna / Tomar, Arvind / Mitra, Lalita Gauri / Prasad, Venkata Siva Tez / Mathur, Rajendra Prasad / Bhattacharya, Debajyoti / Sarin, Shiv Kumar

    Journal of clinical and translational hepatology

    2020  Volume 8, Issue 4, Page(s) 467–473

    Abstract: ... liver transplant recipients. Out of those six patients, three had mild, one had moderate and one had severe COVID ... morbidities. Liver transplant and immunosuppressant medication predisposes to more severe disease and is often ... of repurposed drugs (i.e. teicoplanin and doxycycline), and watchful monitoring of asymptomatic recipients ...

    Abstract The severe acute respiratory syndrome corona virus-2 (referred to as SARS CoV2) pandemic had a great impact on public life in general as well as on populations with pre-existing disease and co-morbidities. Liver transplant and immunosuppressant medication predisposes to more severe disease and is often associated with poor outcome. The clinical features, disease course, treatment and process of modulating the immunosuppression is challenging. Here, we describe the clinical presentation, treatment and outcomes in six liver transplant recipients. Out of those six patients, three had mild, one had moderate and one had severe COVID-19, and one was asymptomatic. The immunosuppression minimization or withdrawal was done based upon the clinical severity. Consideration of tocilizumab and/o convalescent plasma as well as antivirals i.e. remdesvir done in severe cases. The routine practice of prophylactic anticoagulation, consideration of repurposed drugs (i.e. teicoplanin and doxycycline), and watchful monitoring of asymptomatic recipients helped to achieve an uneventful recovery.
    Language English
    Publishing date 2020-10-10
    Publishing country China
    Document type Case Reports
    ZDB-ID 3019822-7
    ISSN 2310-8819 ; 2225-0719
    ISSN (online) 2310-8819
    ISSN 2225-0719
    DOI 10.14218/JCTH.2020.00061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical Practice Issues for Liver Transplantation in COVID-19 Recovered Recipients.

    Shetty, Kirti / Lominadze, Zurabi / Saharia, Kapil / Challa, Suryanarayana Reddy / Montenegro, Maria / Meier, Raphael P H / Malik, Saad / Alvarez-Casas, Josue / Sakiani, Sasan / Jakhete, Neha / Urrunaga, Nathalie / Gray, Stephen H / Maluf, Daniel G

    Progress in transplantation (Aliso Viejo, Calif.)

    2022  Volume 32, Issue 2, Page(s) 148–151

    Abstract: ... experience with two COVID-19 recovered recipients who died shortly after transplant, we adjusted our center ... COVID-19 recovered recipients. There were two early deaths and 5 successful outcomes. Both deceased ... challenges that confront transplant centers in the COVID-19 era and could guide future discussions regarding ...

    Abstract The ongoing burden of COVID-19 in persons with end stage liver failure necessitates the development of sound and rational policies for organ transplantation in this population. Following our initial experience with two COVID-19 recovered recipients who died shortly after transplant, we adjusted our center policies, re-evaluated outcomes, and retrospectively analyzed the clinical course of the subsequent seven COVID-19 recovered recipients. There were two early deaths and 5 successful outcomes. Both deceased patients shared common characteristics in that they had positive SARS-CoV2 PCR tests proximal to transplant (7-17 days), had acute on chronic liver failure, and suffered thromboembolic phenomena. After a careful review of clinical and virological outcome predictors, we instituted policy changes to avoid transplantation in these circumstances. We believe that our series offers useful insights into the unique challenges that confront transplant centers in the COVID-19 era and could guide future discussions regarding this important area.
    MeSH term(s) COVID-19 ; End Stage Liver Disease/surgery ; Humans ; Liver Transplantation ; RNA, Viral ; Retrospective Studies ; SARS-CoV-2 ; Transplant Recipients
    Chemical Substances RNA, Viral
    Language English
    Publishing date 2022-04-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2864264-8
    ISSN 2164-6708 ; 1526-9248
    ISSN (online) 2164-6708
    ISSN 1526-9248
    DOI 10.1177/15269248221092742
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Organ recovery from deceased donors with prior COVID-19: A case series.

    Neidlinger, Nikole A / Smith, Jeannina A / D'Alessandro, Anthony M / Roe, David / Taber, Tim E / Pereira, Marcus R / Friedman, Amy L

    Transplant infectious disease : an official journal of the Transplantation Society

    2020  Volume 23, Issue 2, Page(s) e13503

    Abstract: ... with a prior history of COVID-19 infection, no data exist regarding successful recovery and transplantation ... we report a case series of six deceased donors with a history of COVID-19 from whom 13 organs were recovered ... from deceased donors who have recovered from COVID-19 should be considered. ...

    Abstract Although guidance documents have been published regarding organ donation from individuals with a prior history of COVID-19 infection, no data exist regarding successful recovery and transplantation from deceased donors with a history of or positive testing suggesting a prior SARS-CoV-2 infection. Here, we report a case series of six deceased donors with a history of COVID-19 from whom 13 organs were recovered and transplanted through several of the nation's organ procurement organizations (OPOs). In addition, at least two potential donors were authorized for donation but with no organs were successfully allocated and did not proceed to recovery. No transmission of SARS-CoV-2 was reported from the six donors to recipients, procurement teams, or hospital personnel. Although more studies are needed, organ donation from deceased donors who have recovered from COVID-19 should be considered.
    MeSH term(s) Adult ; Bronchoalveolar Lavage Fluid/chemistry ; Bronchoalveolar Lavage Fluid/virology ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19/transmission ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing ; Female ; Heart Transplantation ; Humans ; Kidney Transplantation ; Liver Transplantation ; Male ; Middle Aged ; SARS-CoV-2 ; Tissue Donors ; Tissue and Organ Harvesting ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-12-01
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.13503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top